fbpx Dr Karl Aoun | NDARC - National Drug and Alcohol Research Centre

Dr Karl Aoun



Dr. Karl Aoun (PhD) joined the University of New South Wales as a Clinical Research Coordinator at the National Drug and Alcohol Research Centre, in August 2020. He is currently working on the Quit Smoking Study investigating the effectiveness, cost-effectiveness and safety of Vaporised Nicotine Products in comparison with Nicotine Replacement Therapy, in Australian low-SES populations of current daily smokers.

Karl completed his PhD (Medicine) at The University of Sydney in 2020. His work explored the anatomical, neuro-chemical and functional attributes of the pre-clinical ultrasound risk marker for Parkinson’s disease in the healthy adult population, with the aim to increase understanding of changes that may occur in the earliest pre-clinical stages of Parkinson’s disease and support the development of methods to better identify this disease stage during life.


ORCID ID: https://orcid.org/0000-0003-1963-9288

University role: 
Clinical Project Coordinator

Doctor of Philosophy (Medicine)